Datroway Injection, Powder, Lyophilized, For Solution
Product Images NDC 65597-801

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Datroway (NDC 65597-801). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Daiichi Sankyo Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Datopotamab 01)

Chemical Structure (Datopotamab 01)
Chemical structure of datopotamab deruxtecan, a conjugate consisting of datopotamab linked to deruxtecan, a topoisomerase I inhibitor. The schematic shows datopotamab bound to a linker attached to multiple deruxtecan molecules.*
FDA Label Image

Figure 1 (Datopotamab 02)

Figure 1 (Datopotamab 02)
A Kaplan-Meier curve chart depicting progression-free survival (%) over time in months since randomization. The chart compares two groups: DATROWAY (n=385) and ICC (n=387), showing survival trends with accompanying numbers at risk below the x-axis for each group at various time points up to 18 months.*
FDA Label Image

Principal Display Panel (100 mg Vial Carton)

Principal Display Panel (100 mg Vial Carton)
DATROWAY 100 mg per vial injection, powder, lyophilized, for solution. The label displays the product name, generic name datopotamab deruxtecan, strength 100 mg per vial, and instructions for intravenous infusion. It includes storage information to keep refrigerated and product handling instructions. Labelers Daiichi Sankyo Inc. and AstraZeneca are shown with their logos. The label also notes the product is hazardous and for prescription use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.